A Novel Analysis of the Pfizer Trial: Vaccine Effectiveness Was Nowhere Near 95%
The natural home for this work is a biomedical journal. There is zero chance, however, that a paper would be accepted by any conventional journal. Why? Because the results are earthshaking, as stated in the title.











